JHX +3.12%: Out with 3Q25 results this morning that were mildly ahead of expectations, though the driver looked to be lower corporate costs.
- 3Q25 earnings (EBIT) of $207 was ahead of $203m consensus.
- NPAT guidance was unchanged at $635m, with consensus at $644m
- Capex guidance was reduced to the bottom of previous $420-440m range.
Overall, a slight beat for the quarter, reiteration of FY guidance, which was pretty much inline with expectations, though there was no commentary on the idle buyback. The stock has been weak leading into the update, so they did enough to see the shares trade higher.
MM remains long & bullish JHX
Add To Hit List
